Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Alventa XL 75mg capsules
0403040W0BTAAAD
|
Alventa | Venlafaxine | Central Nervous System | 18 |
|
Aricept Evess 5mg orodispersible tablets
0411000D0BBACAD
|
Aricept | Donepezil hydrochloride | Central Nervous System | 18 |
|
Clonazepam 2mg/5ml oral liquid
0408010F0AABSBS
|
Clonazepam (Systemic) | Clonazepam | Central Nervous System | 18 |
|
Diamorphine 10mg tablets
0407020K0AACBCB
|
Diamorphine hydrochloride (Systemic) | Diamorphine hydrochloride (Systemic) | Central Nervous System | 18 |
|
Midazolam 12.5mg/5ml oral liquid
0408020V0AAAEAE
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | 18 |
|
Politid XL 75mg capsules
0403040W0BMAAAD
|
Politid | Venlafaxine | Central Nervous System | 18 |
|
Quetiapine 25mg/5ml oral solution
0402010ABAAAHAH
|
Quetiapine | Quetiapine | Central Nervous System | 18 |
|
Reagila 3mg capsules
0402010AJBBABAB
|
Reagila | Cariprazine | Central Nervous System | 18 |
|
Risperdal 6mg tablets
040201030BBAFAF
|
Risperdal | Risperidone | Central Nervous System | 18 |
|
Venlaneo XL 75mg capsules
0403040W0BWAAAD
|
Venlaneo | Venlafaxine | Central Nervous System | 18 |
|
Zonisamide 25mg/5ml oral suspension
0408010ADAAAFAF
|
Zonisamide | Zonisamide | Central Nervous System | 18 |
|
Zonisamide 50mg/5ml oral solution
0408010ADAAADAD
|
Zonisamide | Zonisamide | Central Nervous System | 18 |
|
Buprenorphine 24mg/0.48ml prolonged-release inj pfs
0410030A0AAAQAQ
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | 17 |
|
Buspirone 30mg tablets
0401020B0AAAFAF
|
Buspirone hydrochloride | Buspirone hydrochloride | Central Nervous System | 17 |
|
Felbamate 600mg tablets
0408010AAAAABAB
|
Felbamate | Felbamate | Central Nervous System | 17 |
|
Fenylat 25micrograms/hour transdermal patches
0407020A0BZABAE
|
Fenylat | Fentanyl | Central Nervous System | 17 |
|
Gaalin 16mg modified-release capsules
0411000F0BMABAF
|
Gaalin | Galantamine | Central Nervous System | 17 |
|
HealthAid 5-HTP HydroxyTryptoPhan 50mg tablets
0403040R0BEAAAK
|
HealthAid 5-HTP | Oxitriptan | Central Nervous System | 17 |
|
Levomepromazine 5mg/5ml oral liquid
0402010K0AAAGAG
|
Levomepromazine maleate | Levomepromazine maleate | Central Nervous System | 17 |
|
Levorol 5mg/ml oral solution
0402010L0BCAAAE
|
Levorol (hydrochloride) | Levomepromazine hydrochloride | Central Nervous System | 17 |
|
Maneo 100mg modified-release tablets
040702040BUAAAC
|
Maneo | Tramadol hydrochloride | Central Nervous System | 17 |
|
Nuromol Dual Action Pain Relief 200mg/500mg tablets
0407010ADBBAAAA
|
Nuromol | Paracetamol and ibuprofen | Central Nervous System | 17 |
|
Phenobarbital 250mg/5ml oral liquid
0408010N0AADIDI
|
Phenobarbital | Phenobarbital | Central Nervous System | 17 |
|
Prozac 20mg/5ml liquid
0403030E0BBABAC
|
Prozac | Fluoxetine hydrochloride | Central Nervous System | 17 |
|
Scopoderm TTS 1.5mg patches
0406000A0BCABAD
|
Scopoderm | Hyoscine | Central Nervous System | 17 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.